←
Hans Messner Allogeneic BMT Program144 posts
Hans Messner Allogeneic BMT Program avatar

Hans Messner Allogeneic BMT Program

@Hans_BMTProgram

Official account of the Hans Messner Allogeneic Blood and Marrow Transplant Program at Princess Margaret Hospital, Toronto. Posts are not medical advice.

◷ Joined March 2020▧ 32 Photos and videos
Hans Messner Allogeneic BMT Program avatar
Hans Messner Allogeneic BMT Program@Hans_BMTProgram·22 Dec 2023

Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).

Post attachmentPost attachmentPost attachmentPost attachment
Hans Messner Allogeneic BMT Program avatar
Hans Messner Allogeneic BMT Program@Hans_BMTProgram·Aug 26

Excellent presentation by Welaia Alsaffar (@welaia_ali): the “best donor” in allo-HCT is not defined by a fixed hierarchy. Disease, urgency and platform matter; HLA match and DSA remain central, with age, CMV status and availability refining the choice.

Post attachment
Ruah Alyamany | روى اليماني avatar
⟳ Hans Messner Allogeneic BMT Program retweeted
Ruah Alyamany | روى اليماني@Ruah_Mahmoud·29 May 2025

Delighted to share our latest publication on the impact of conditioning intensity in younger AML patients receiving dual T-cell depletion for GVHD prophylaxis. #Hematology #BMT @AhmedAlNughmush @Hans_BMTProgram doi.org/10.1111/ejh.14438

𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM avatar
⟳ Hans Messner Allogeneic BMT Program retweeted
𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM@nihardesai89·18 May 2025

Excellent thread summarising key findings of our latest publication from @pmcancercentre 👇🏽 DM me if you want the PDF 🙌🏽 onlinelibrary.wiley.com/doi/… #MedTwitter @SergioRdzRdz @Hans_BMTProgram @Haemophage

Post attachment

🚨 New Study Alert! @nihardesai89 @Haemophage @IvanPasic Our team retrospectively analyzed our cohort on allogeneic HSCT outcomes in patients with MDS/MPN overlap syndromes—a rare and challenging group of hematologic neoplasms. 🧵👇